Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA–KIDNEY by Nangaku, M, Herrington, WG, Goto, S, Maruyama, S, Kashihara, N, Ueki, K, Wada, J, Watada, H, Nakashima, E, Lee, R, Massey, D, Mayne, KJ, Tomita, A, Haynes, R, Hauske, SJ, Kadowaki, T

A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes by Taira, M, Imamura, M, Takahashi, A, Kamatani, Y, Yamauchi, T, Araki, S, Tanaka, N, van Zuydam, N, Ahlqvist, E, Toyoda, M, Umezono, T, Kawai, K, Imanishi, M, Watada, H, Suzuki, D, Maegawa, H, Babazono, T, Kaku, K, Kawamori, R, Summit Consortium, Groop, L, McCarthy, M, Kadowaki, T, Maeda, S